IP Library › Granted Patent US 10,123,999
Granted Patent B2
US 10,123,999 · App. 15/348,716 · Granted Nov 13, 2018

Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds

Inventor: Jo Ann Wilson (San Francisco, CA)
Assignee: Exelixis, Inc.
A61K31/47C07D215/233
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,123,999
App. No.
15/348,716
Granted
Nov 13, 2018
Kind
B2
Abstract

The present invention is directed to processes for making and compositions containing quinolines such as formula I or pharmaceutically acceptable salts thereof wherein: X1 is H, Br, Cl, or X2 is H, Br, Cl, or n1 is 1-2; and n2 is 1-2.

Claims (32)

1. A process for preparing a compound of formula I:

or a pharmaceutically acceptable salt thereof, wherein:

X 1 is H, Br, Cl, or F;

X 2 is H, Br, Cl, or F;

n1 is 1-2; and

n2 is 1-2;

the process comprising:

reacting a compound of formula f(1) with a reactant y(1) in the presence of a non-nucleophilic base which is an alkali metal alkoxide to yield the compound of formula g(1):

wherein LG represents a leaving group; and

contacting a compound of formula g(1) with a reactant z(1) to yield the compound of formula I:

2. The process according to claim 1 , wherein the compound of formula f(1) is made by converting a compound of formula e(1) to the compound of formula f(1):

wherein LG represents a leaving group.

3. The process according to claim 1 , wherein reactant z(1) is made by reacting a reactant z(1a) with a chlorinating agent to yield the reactant z(1):

wherein X 1 is Br, Cl, or F; and n1 is 1-2.

4. The process according to claim 1 , wherein the compound of formula I is a compound of formula IA-1:

or a pharmaceutically acceptable salt thereof, wherein:

X 1 is H, Cl, Br, or F; and

X 2 is H, Cl, Br, or F.

5. The process according to claim 1 , wherein

the compound of formula f(1) is the compound f(2):

the reactant y(1) is a reactant (y)(2):

wherein X 2 is hydrogen or fluoro; and

the compound of formula g(1) is a compound of formula g(2):

6. The process according to claim 1 , wherein the reaction is carried out in a polar solvent.

7. The process according to claim 6 , wherein the alkali metal alkoxide is sodium tert-butoxide, and the polar solvent is DMA.

8. The process according to claim 6 , wherein the alkali metal alkoxide is sodium tert-pentoxide, and the polar solvent is DMA.

9. The process according to claim 3 , wherein the compound of formula g(1) is the compound g(3):

the reactant z(la) is the reactant (z)(2):

and

the compound of formula I is the compound of formula IA:

10. The process according to claim 9 , wherein the reaction is carried out in the presence of an inorganic base.

11. The process according to claim 10 , wherein the inorganic base is K 2 CO 3 , and the reaction is carried out in a solvent comprising a combination of THF and H 2 O.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2023
From: WILSON, JO ANN
To: EXELIXIS, INC.
Reel/Frame 063036/0972 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2018
From: WILSON, JO ANN
To: EXELIXIS, INC.
Reel/Frame 046496/0905 →
Continuity (4)
Division 13984559
Provisional Application 61441520 · Feb 10, 2011
Provisional Application 61441527 · Feb 10, 2011
Related Publication 20170057921A1 · Mar 2, 2017
Cited By (7)
US 12,415,784 US 12,516,025 US 12,516,026 US 12,522,567 US 12,552,749 US 12,661,350 US 12,741,938